Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 8:17 PM UTC
| NCT Number | NCT05892393 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Robert Flavell, MD, PhD |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of July 20, 2026: Clinical trial NCT05892393 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Robert Flavell, MD, PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05892393 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05892393 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.